Calcium alginate provides a high degree of embolization in aneurysm models: a specific comparison to coil packing.
OBJECTIVE
Although flexible, current coils do not fill intracranial aneurysms to a high degree, and questions remain regarding their thrombogenic capacity. We evaluated the usefulness of calcium alginate as an embolic material for endovascular embolization in aneurysm models.


METHODS
We assessed three endovascular methods of instilling calcium alginate into 10-mm sidewall and 7-mm bifurcation glass aneurysm models using a balloon catheter to seal the aneurysm orifice: 1) instillation of alginate and subsequent instillation of the reactive component calcium chloride (CaCl(2)) via a single-lumen catheter, 2) simultaneous instillation of alginate and CaCl(2) via a side-by-side double-lumen catheter, and 3) instillation of alginate mixed with CaCl(2) delivered from a concentric-tube microcatheter. A 13-mm sidewall silicon aneurysm model was used to measure and compare the volume of calcium alginate occupying the aneurysm models.


RESULTS
Instillation Method 1 did not achieve optimal filling of the aneurysm with calcium alginate. The percentage volumes of calcium alginate occupying the aneurysm were 69.2 +/- 7.7% and 84.6 +/- 5.4% for instillation Methods 2 and 3, respectively. In Method 3, calcium alginate began gelation upon leaving the catheter, entered the aneurysms in a strand form, and gelled to a mass that filled the aneurysm while conforming to its inner contour.


CONCLUSIONS
Calcium alginate fills aneurysm models to a significantly higher degree than published results of the space filled by coils. Instillation of calcium alginate, especially in strand form, may produce an embolization that better fills and conforms to the contour of aneurysms compared with coils.
Soga
Youji
Y
Division of Neurological Surgery and Neurosurgery Research Laboratory, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona 85013, USA.
Preul
Mark C
MC
Furuse
Motomasa
M
Becker
Timothy
T
McDougall
Cameron G
CG
D000464:Alginates / Q000378:metabolism / Q000627:therapeutic use*; D002404:Catheterization / Q000379:methods; D004621:Embolization, Therapeutic / Q000379:methods*; D004864:Equipment and Supplies; D005898:Glass; D020723:Glucuronic Acid / Q000378:metabolism / Q000627:therapeutic use*; D006603:Hexuronic Acids / Q000378:metabolism / Q000627:therapeutic use*; D002532:Intracranial Aneurysm / Q000628:therapy*; D008954:Models, Biological; D012107:Research Design; D012825:Silicon / Q000378:metabolism
D000464:Alginates; D006603:Hexuronic Acids; D020723:Glucuronic Acid; D012825:Silicon